News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Daily News CVD Still the Leading Cause of Death and Disease Globally Michael O'Riordan September 24, 2025
News Conference News ESC 2025 WHF Stresses the Importance of Polypills in Global Fight Against CVD Yael L. Maxwell September 09, 2025
News Daily News Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050 Todd Neale July 16, 2025
News Daily News FDA Approves Triple Therapy Polypill for High Blood Pressure Michael O'Riordan June 10, 2025
News Daily News Use of Secondary CVD Prevention Meds Still Meager Worldwide Caitlin E. Cox February 03, 2025
News Daily News Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE Yael L. Maxwell September 23, 2024
News Daily News Aspirin as Secondary Prevention Still Subpar, Especially in Lower-Income Countries Caitlin E. Cox August 24, 2023
News Daily News Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees Michael O'Riordan January 05, 2023
News Conference News ESC 2021 New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy Michael O'Riordan September 03, 2021
News Daily News Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data Michael O'Riordan July 14, 2020
News Daily News US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable Shelley Wood May 29, 2020
News Daily News No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests Yael L. Maxwell May 21, 2020
News Daily News PolyIran: Polypill Prevents Major Cardiovascular Events Over 5 Years Todd Neale August 23, 2019
News Features The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine Shelley Wood October 22, 2018
News Features Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives Yael L. Maxwell January 12, 2018
News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Daily News Evolocumab Not Cost-Effective at Current List Price Michael O'Riordan August 23, 2017
News Daily News Many Guidelines, Mixed Consensus: Different CVD Risk Guidelines Cause Confusion in Practice Michael O'Riordan September 16, 2016